Pharmacokinetic and tissue distribution studies of 1,9-pyrazoloanthrone, a c-Jun-N-terminal kinase inhibitor in Wistar rats by a simple and sensitive HPLC method

[Display omitted] •The HPLC method was developed and validated.•This method was successfully applied to pharmacokinetic and tissue distribution study in Wistar rats.•The liposomal 1,9-pyrazoloanthrone formulation significantly improved bioavailability in brain.•The comparison of bioavailability and...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical and biomedical analysis Vol. 120; pp. 57 - 64
Main Authors: Ambhore, Nilesh Sudhakar, Yamjala, Karthik, Mohire, Shubhashri, Raju, Kalidhindi Rama Satyanarayana, Mulukutla, Shashank, Murthy, Vishakantha, Tondhawada, Mahesh, Elango, Kannan
Format: Journal Article
Language:English
Published: England Elsevier B.V 20-02-2016
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] •The HPLC method was developed and validated.•This method was successfully applied to pharmacokinetic and tissue distribution study in Wistar rats.•The liposomal 1,9-pyrazoloanthrone formulation significantly improved bioavailability in brain.•The comparison of bioavailability and brain distribution of standard 1,9-pyrazoloanthrone and 1,9-pyrazoloanthrone liposomal formulation was carried out. JNK pathway activates c-Jun(s) which are responsible for cell apoptosis; as a result, inhibitors of JNK pathway have the potential to prevent dopaminergic neurons from death and decrease the loss of dopamine in substantia nigra pars compacta (SNpc). Recent in-vitro studies show that 1,9-pyrazoloanthrone (1,9-P) a potent JNK-3 inhibitor prevents the apoptosis of dopaminergic cells of brain. In the present study we formulated liposomes to increase the bioavailability of 1,9-P in the brain and developed a simple, sensitive and selective high performance liquid chromatographic method and validated for the estimation of 1,9-P in Wistar rat plasma and tissue samples. Plasma and tissue samples were extracted by protein precipitation technique using acetonitrile (ACN) and rasagiline as the internal standards. Chromatography was performed on Hibar C18 column with mobile phase of ammonium acetate (10mM, pH 8.0 adjusted with ammonia) and ACN at a flow rate of 1mL/min. The lower limit of quantification of the developed method was found to be 2.0ng/mL and 4.0ng/g in plasma and tissue samples respectively. The liposomes of 1,9-P administered to animals at the dose equivalent to 15mg/kg orally demonstrated remarkable absorption into the systemic circulation with maximum concentration (∼7500ng/mL) within 2.0h. The order of the area under curve was found to be kidney>liver>brain>lungs>spleen>heart. The liposomes of 1,9-P were rapidly taken up into brain and showed a good brain concentration after 2.0h; sustenance up to 4.0h was achieved which is better than 1,9-P solution.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0731-7085
1873-264X
DOI:10.1016/j.jpba.2015.12.004